CENTESSA PHARMACEUTICALS (260) — Defensive Interval Ratio
CENTESSA PHARMACEUTICALS (260) has a Defensive Interval Ratio of 2137 days as of March 2026. Defensive assets of €214.16 Million (cash €-, short-term investments €214.16 Million, receivables €-) cover 2137 days of daily cash needs of €100.20K/day. Explore CENTESSA PHARMACEUTICALS (260) investment intensity to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
CENTESSA PHARMACEUTICALS Defensive Interval Ratio (2022–2025)
This chart shows how CENTESSA PHARMACEUTICALS's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 2137 days, meaning defensive assets of €214.16 Million can fund 2137 days of operations without new revenue. Read 260 total debt and obligations for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for CENTESSA PHARMACEUTICALS (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for CENTESSA PHARMACEUTICALS from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see balance sheet size of CENTESSA PHARMACEUTICALS.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1983 days | €233.28 Million | €117.63K/day | €- | €233.28 Million | ▲ +1360 days |
| 2024 | 623 days | €98.96 Million | €158.90K/day | €- | €98.96 Million | ▼ -568 days |
| 2023 | 1191 days | €128.52 Million | €107.90K/day | €- | €128.52 Million | ▲ +1191 days |
| 2022 | 0 days | €0.00 | €105.04K/day | €- | €0.00 | — |